Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival

被引：11

作者：

Rastellini, C

Salam, A

Kuddus, R

Aitouche, A

Subbotin, V

Braun, M

Leach, R

Peach, R

Fung, JJ

Starzl, TE

Rao, AS

机构：

[1] Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Sect Cellular Transplantat, Pittsburgh, PA USA

[2] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA

[3] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA

[4] Bristol Myers Squibb, Princeton, NJ USA

来源：

TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 1-2期

关键词：

D O I：

10.1016/S0041-1345(98)01979-4

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1242 / 1243

页数：2

共 5 条

[1]

KENYON N, 1998, 24 ANN SCI M AM SOC

[2] CTLA4-Ig and anti-CD4O ligand prevent renal allograft rejection in primates [J].

Kirk, AD ;

Harlan, DM ;

Armstrong, NN ;

Davis, TA ;

Dong, YC ;

Gray, GS ;

Hong, XN ;

Thomas, D ;

Fechner, JH ;

Knechtle, SJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8789-8794

[3] Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways [J].

Larsen, CP ;

Elwood, ET ;

Alexander, DZ ;

Ritchie, SC ;

Hendrix, R ;

TuckerBurden, C ;

Cho, HR ;

Aruffo, A ;

Hollenbaugh, D ;

Linsley, PS ;

Winn, KJ ;

Pearson, TC .

NATURE, 1996, 381 (6581) :434-438

[4]

Levisetti MG, 1997, J IMMUNOL, V159, P5187

[5]

SUN H, 1997, TRANSPLANTATION, V64, P1828

← 1 →